mail
versión imprimible
 
 

2nd Rare CNS and Neurodevelopmental Drug Development Summit

Evvnt Promotion / evvnt
-
28.11.2022 - 30.11.2022  Wyndham Boston Beacon Hill, 5 Blossom Street, 02114 Boston, Massachusetts, USA
Time: 8:00 am - 3:50 pm
 
Temas de la conferencia
With further clinical data emerging, drug development for rare CNS and neurodevelopmental disorders is advancing from hypotheticals to real-life clinical results, outcomes, and functional biomarkers; catapulting this critical field forwards to change patients' lives.

The 2nd Rare CNS and Neurodevelopmental Drug Development Summit is the definitive industry-dedicated forum for large pharma, biotech, academia, and patient advocacy groups, paving the way towards symptomatic and successful disease
Organizador profesional (PCO)
Hanson Wade
Observaciones
URL:
Brochure: https://go.evvnt.com/1289306-3?pid=4832

Speakers: Alfica Sehgal, Senior Vice President, Head of Discovery and Translation, CAMP4 Therapeutics and more.
 

Información e inscripción:

https://go.evvnt.com/1289306-2?pid=4832
Ms. Emily Lincoln
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
USD 2599.00 - USD 5846.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

newTreeEuropean Health Forum GasteinCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÄrztekammer für WienHilfswerk AustriaEuropean Public Health Association (EUPHA)Helix - Forschung & Beratung WienOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation